| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.JCLINEPI.2006.10.020 |
| P698 | PubMed publication ID | 17573977 |
| P50 | author | Pablo Alonso-Coello | Q28468923 |
| Jason W. Busse | Q30349396 | ||
| Dianne M Bryant | Q64764226 | ||
| Ignacio Ferreira-González | Q87773157 | ||
| Gaietà Permanyer-Miralda | Q117264416 | ||
| Gordon Guyatt | Q5585214 | ||
| Victor Montori | Q7926167 | ||
| P2093 | author name string | Stephen D Walter | |
| P433 | issue | 7 | |
| P304 | page(s) | 651-7; discussion 658-62 | |
| P577 | publication date | 2007-02-23 | |
| P1433 | published in | Journal of Clinical Epidemiology | Q6294959 |
| P1476 | title | Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns | |
| P478 | volume | 60 |
| Q40135493 | A DAG-based comparison of interventional effect underestimation between composite endpoint and multi-state analysis in cardiovascular trials |
| Q92262716 | A patient-centered composite endpoint weighting technique for orthopaedic trauma research |
| Q34670467 | A randomised controlled trial comparing standard or intensive management of reduced fetal movements after 36 weeks gestation--a feasibility study. |
| Q42912178 | An empirically based tool for analyzing morbidity associated with operations for congenital heart disease |
| Q33569474 | An optimal Wilcoxon-Mann-Whitney test of mortality and a continuous outcome |
| Q38067300 | Are all outcomes in chronic heart failure rated equally? An argument for a patient-centred approach to outcome assessment |
| Q39628955 | Beyond Composite Endpoints Analysis: Semicompeting Risks as an Underutilized Framework for Cancer Research |
| Q60302598 | Bin-CE: A comprehensive web application to decide upon the best set of outcomes to be combined in a binary composite endpoint |
| Q26799831 | Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles: A Consensus Document From the Mitral Valve Academic Research Consortium |
| Q46573703 | Clinical Trial Opportunities in Transfusion Medicine: Proceedings of a National Heart, Lung, and Blood Institute State-of-the-Science Symposium |
| Q38863496 | Clinical Trials Targeting Aging and Age-Related Multimorbidity |
| Q33900204 | Clinical Trials in Veterinary Medicine: A New Era Brings New Challenges |
| Q38546450 | Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: A consensus document from the mitral valve academic research consortium |
| Q92159009 | Coherence in measurement and programming in maternal and newborn health: experience from the BetterBirth trial |
| Q39599907 | Competing risks analyses: objectives and approaches. |
| Q38154679 | Composite endpoints in trials of type-2 diabetes |
| Q34073347 | Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review |
| Q33872146 | Delphi-consensus weights for ischemic and bleeding events to be included in a composite outcome for RCTs in thrombosis prevention |
| Q56493157 | Development of a composite endpoint for randomized controlled trials in liver surgery |
| Q38173667 | Development of a composite endpoint for randomized controlled trials in pancreaticoduodenectomy. |
| Q37257372 | Effectiveness and safety of glimepiride and iDPP4, associated with metformin in second line pharmacotherapy of type 2 diabetes mellitus: systematic review and meta-analysis. |
| Q37593632 | Efficacy of a novel formulation of L-Carnitine, creatine, and leucine on lean body mass and functional muscle strength in healthy older adults: a randomized, double-blind placebo-controlled study |
| Q42046724 | Establishment of an index with increased sensitivity for assessing murine arthritis. |
| Q34602085 | Gabapentin versus tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia: discrepancies between direct and indirect meta-analyses of randomized controlled trials |
| Q38545232 | Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials |
| Q48076465 | Health-related quality of life after myocardial infarction, does choice of method make a difference? |
| Q42618233 | Identifying outcomes of clinical genetic services: qualitative evidence and methodological considerations. |
| Q57482767 | Impact of weighted composite compared to traditional composite endpoints for the design of randomized controlled trials |
| Q92180071 | Imputation strategies when a continuous outcome is to be dichotomized for responder analysis: a simulation study |
| Q53820837 | Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study. |
| Q55478511 | Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study. |
| Q33606234 | Individual and composite study endpoints: separating the wheat from the chaff |
| Q42226623 | Influence of early goal-directed therapy using arterial waveform analysis on major complications after high-risk abdominal surgery: study protocol for a multicenter randomized controlled superiority trial. |
| Q47997750 | Intermittent preventive therapy for malaria with monthly artemether-lumefantrine for the post-discharge management of severe anaemia in children aged 4-59 months in southern Malawi: a multicentre, randomised, placebo-controlled trial. |
| Q38611474 | Interpreting a randomized trial report: evidence-based practice for the clinician |
| Q86651438 | Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear |
| Q57313781 | Magnitude of effects in clinical trials published in high-impact general medical journals |
| Q37692734 | Methodological issues in the use of composite endpoints in clinical trials: examples from the HIV field |
| Q35752562 | Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines |
| Q43245092 | Misspecification of Cox regression models with composite endpoints |
| Q46207630 | On the analysis of composite measures of quality in medical research |
| Q36475499 | Peritoneal dialysis patients with critical illness: insurance may be hard to come by. |
| Q85849976 | Prednisone for community-acquired pneumonia: not yet time |
| Q57044288 | Protocol for the Lactoferrin Infant Feeding Trial (LIFT): a randomised trial of adding lactoferrin to the feeds of very-low birthweight babies prior to hospital discharge |
| Q47225627 | RePHILL: protocol for a randomised controlled trial of pre-hospital blood product resuscitation for trauma. |
| Q45238029 | Reply: Quality-adjusted life years or composite outcomes? |
| Q39326663 | Research in cardiovascular care: a position statement of the Council on Cardiovascular Nursing and Allied Professionals of the European Society of Cardiology |
| Q33881505 | Role and rationale for the use of milnacipran in the management of fibromyalgia |
| Q41327832 | Selecting the primary endpoint in a randomized clinical trial: The ARE method |
| Q48200963 | Selection of composite binary endpoints in clinical trials |
| Q40803504 | Selection of the primary end point in an observational cohort study |
| Q35741035 | Skin Stretching for Burn Scar Excision - A Critically Appraised Topic |
| Q36068850 | Specificity of Genetic Biomarker Studies in Cancer Research: A Systematic Review. |
| Q44656052 | Statistical properties of continuous composite scales and implications for drug development |
| Q38074456 | The Combined Assessment of Function and Survival (CAFS): a new endpoint for ALS clinical trials |
| Q40246134 | The Use of a Binary Composite Endpoint and Sample Size Requirement: Influence of Endpoints Overlap |
| Q28602669 | The effect of tranexamic acid on the risk of death and hysterectomy in women with post-partum haemorrhage: statistical analysis plan for the WOMAN trial |
| Q39361032 | The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities |
| Q38978970 | Weighted analysis of composite endpoints with simultaneous inference for flexible weight constraints |
| Q41883020 | When novelty is not enough |
| Q51904874 | [Combined endpoints]. |
Search more.